アジア太平洋のデジタルPCR市場：用途別、エンドユーザー別、国別 - 分析と予測（2024年～2034年）

アジア太平洋のデジタルPCR（d-PCR）の市場規模は、2024年の1億4,440万米ドルから2034年には6億9,550万米ドルに達すると予測され、予測期間の2024年～2034年のCAGRは17.02%になると予測されています。

遺伝性疾患のスクリーニングと診断のための個別化医療の利用の拡大が、アジア太平洋のデジタルPCR市場の2桁成長を推進しています。デジタルPCR（dPCR）は、様々ながんに関連する珍しい遺伝子変異を正確に同定・測定するために、この患者に特化した手法で使用されます。迅速で正確な診断ソリューションへのニーズは、この地域の感染症流行の高まりによっても煽られています。液滴デジタルPCR、ナノプレート技術、マイクロ流体プラットフォームは、dPCRの能力を向上させ、アジア太平洋地域における市場の成長を大きく後押ししている技術的進歩の一例です。

アジア太平洋地域では、デジタルポリメラーゼ連鎖反応（dPCR）市場が2桁台の力強い成長を遂げており、最先端の診断技術として急速に普及しています。臨床および研究におけるdPCRの広範な使用は、政府プログラムの増加、ヘルスケアインフラへの投資の増加、研究資金の改善によって後押しされています。感染症、遺伝性疾患、がんの罹患率の上昇により、疾患の早期発見と効率的な治療モニタリングのための高精度診断の必要性がアジア太平洋で高まっています。

先進のdPCR技術は感度、特異性、スループットを大幅に向上させています。これらの技術の例としては、液滴デジタルPCR、ナノプレートシステム、マイクロ流体プラットフォームなどがあります。これらの開発は、珍しい遺伝子変異のような低存在量のバイオマーカーの正確な定量を可能にすることで、標的治療や個別化医療をサポートします。さらに、自動化と直感的なソフトウェアインターフェースの進歩によって可能になった標準的な臨床ワークフローへのスムーズな統合により、迅速なターンアラウンドタイムと低い運用コストが達成されつつあります。

アジア太平洋のデジタルPCR市場は、さらなる成長と技術的進歩のために有利な位置にあり、最終的にこの地域全体の分子診断の状況を変えると思われます。その背景には、この地域特有の臨床課題に対する解決策を生み出すために、業界をリードする既存企業と新進気鋭の新興企業の両方が研究開発に投資しているという事実があります。

当レポートでは、アジア太平洋のデジタルPCR市場について調査し、市場の概要とともに、用途別、エンドユーザー別、国別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

第1章 市場

• 市場概要
• 動向：現在および将来の影響評価
• サプライチェーンの概要
• 研究開発レビュー
• 進行中のデジタルPCR臨床試験
• 市場力学の概要

第2章 地域

• 地域別概要
• 促進要因と抑制要因
• アジア太平洋

第3章 市場-競合ベンチマーキングと企業プロファイル

• 競合情勢
• 市場シェア分析
• 企業プロファイル
  • Genetron Holdings Limited
  • RevoSketch Inc.
  • JN Medsys
  • Sysmex Corporation

第4章 調査手法

List of Figures

• Figure 1: Asia-Pacific Digital PCR Market (by Application), $Million 202, 2029 and 2034
• Figure 2: Asia-Pacific Digital PCR Market (by End User), $Million, 2023, 2029, and 2034
• Figure 3: Key Events to Keep Track of in the Digital PCR Market
• Figure 4: Supply Chain and Risks within the Supply Chain
• Figure 5: Digital PCR Market (by Region), January 2020-September 2024
• Figure 6: Digital PCR Market (by Country), January 2020-September 2024
• Figure 7: Digital PCR Market (by Year), January 2020-September 2024
• Figure 8: Impact Analysis of Market Navigating Factors, 2024-2034
• Figure 9: China Digital PCR Market, $Million, 2023-2034
• Figure 10: Australia Digital PCR Market, $Million, 2023-2034
• Figure 11: South Korea Digital PCR Market, $Million, 2023-2034
• Figure 12: Japan Digital PCR Market, $Million, 2023-2034
• Figure 13: Rest-of-Asia-Pacific Digital PCR Market, $Million, 2023-2034
• Figure 14: Strategic Initiatives, January 2019-September 2024
• Figure 15: Share of Strategic Initiatives, January 2019-September 2024
• Figure 16: Data Triangulation
• Figure 17: Top-Down and Bottom-Up Approach (Segment-Wise Analysis)
• Figure 18: Assumptions and Limitations

List of Tables

• Table 1: Market Snapshot
• Table 2: Opportunities across Regions
• Table 3: Comparison of qPCR and dPCR
• Table 4: Digital PCR Market, Trend Analysis
• Table 5: Digital PCR Market, Recent Product Launches
• Table 6: Some of the Ongoing Digital PCR (d-PCR) Clinical Trials
• Table 7: Regulatory Framework
• Table 8: Funding Allocated for Precision Medicine to Different Agencies Globally
• Table 9: Cost for Different Commercialized Digital PCR (d-PCR) Platforms
• Table 10: Digital PCR Market (by Region), $Million, 2023-2034
• Table 11: Asia-Pacific Digital PCR Market (by Application), $Million, 2023-2034
• Table 12: Asia-Pacific Digital PCR Market (by End User), $Million, 2023-2034
• Table 13: China Digital PCR Market (by Application), $Million, 2023-2034
• Table 14: China Digital PCR Market (by End User), $Million, 2023-2034
• Table 15: Australia Digital PCR Market (by Application), $Million, 2023-2034
• Table 16: Australia Digital PCR Market (by End User), $Million, 2023-2034
• Table 17: South Korea Digital PCR Market (by Application), $Million, 2023-2034
• Table 18: South Korea Digital PCR Market (by End User), $Million, 2023-2034
• Table 19: Japan Digital PCR Market (by Application), $Million, 2023-2034
• Table 20: Japan Digital PCR Market (by End User), $Million, 2023-2034
• Table 21: Rest-of-Asia-Pacific Digital PCR Market (by Application), $Million, 2023-2034
• Table 22: Rest-of-Asia-Pacific Digital PCR Market (by End User), $Million, 2023-2034

Introduction to Asia-Pacific Digital PCR Market

The Asia-Pacific digital PCR (d-PCR) market is projected to reach $695.5 million by 2034 from $144.4 million in 2024, growing at a CAGR of 17.02% during the forecast period 2024-2034. The growing use of personalised medicine for genetic disorder screening and diagnosis has propelled the APAC digital PCR market's double-digit growth. Digital PCR (dPCR) is used in this patient-specific method to precisely identify and measure uncommon genetic mutations connected to a range of cancers. The need for quick and accurate diagnostic solutions is also being fuelled by the region's rising infectious disease prevalence. Droplet digital PCR, nanoplate technology, and microfluidic platforms are examples of technological advancements that are improving dPCR capabilities and greatly bolstering the market's growth in the Asia-Pacific area.

Market Introduction

The Asia-Pacific (APAC) region is seeing strong, double-digit growth in the digital polymerase chain reaction (dPCR) market, which is quickly becoming popular as a state-of-the-art diagnostic technique. The broad use of dPCR in clinical and research applications is being fuelled by increased government programs, increased investments in healthcare infrastructure, and improved research funding. The need for high-precision diagnostics that facilitate early disease detection and efficient treatment monitoring is increasing in APAC due to the rising incidence of infectious diseases, genetic disorders, and cancers.

Advanced dPCR technologies have greatly increased sensitivity, specificity, and throughput. Examples of these technologies include droplet digital PCR, nanoplate systems, and microfluidic platforms. These developments support targeted therapies and personalised medicine by enabling the accurate quantification of low-abundance biomarkers, such as uncommon genetic mutations. Additionally, quicker turnaround times and lower operating costs are being achieved through smooth integration into standard clinical workflows made possible by advancements in automation and intuitive software interfaces.

The APAC digital PCR market is well-positioned for further growth and technological advancement, which will ultimately change the molecular diagnostics landscape throughout the region. This is due to the fact that both established industry leaders and up-and-coming startups are investing in research and development to create solutions for the region's particular clinical challenges.

Market Segmentation:

Segmentation 1: by Application

• Clinical and Research Application
• Environmental Application
• Other Application

Segmentation 2: by End User

• Academic and Research Institutes
• Hospitals and Clinics
• Diagnostic Centers
• Pharmaceutical and Biopharmaceutical Companies
• Other End User

Segmentation 3: by Country

• China
• Japan
• South Korea
• Australia
• Rest-of-Asia-Pacific

How can this report add value to an organization?

Product/Innovation Strategy: The Asia-Pacific digital PCR market has been extensively segmented based on various categories, such as application, end user, and country. This can help readers understand which segments account for the largest share and which are well-positioned to grow in the coming years.

Competitive Strategy: The Asia-Pacific digital PCR market has numerous established players with product portfolios. Key players in the APAC digital PCR market analyzed and profiled in the study involve established players offering products for digital PCR.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts, who have analyzed company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

• RevoSketch Inc.
• JN Medsys
• Sysmex Corporation

Table of Contents

Executive Summary

Scope and Definition

1 Markets

• 1.1 Market Overview
  • 1.1.1 Workflow of Digital PCR
  • 1.1.2 Comparison of qPCR and dPCR
• 1.2 Trends: Current and Future Impact Assessment
  • 1.2.1 Integration with Next-Generation Sequencing (NGS)
  • 1.2.2 Increased Real-time Monitoring and Point-of-care Applications of Digital PCR
  • 1.2.3 Increasing Product Launches in d-PCR Ecosystem
• 1.3 Supply Chain Overview
• 1.4 Research and Development Review
  • 1.4.1 Patent Filing Trend (by Region)
  • 1.4.2 Patent Filing Trend (by Country)
  • 1.4.3 Patent Filing Trend (by Year)
• 1.5 Ongoing Digital PCR Clinical Trials
• 1.6 Regulatory Landscape
  • 1.6.1 Asia Pacific
    • 1.6.1.1 Japan
    • 1.6.1.2 China
• 1.7 Market Dynamics Overview
  • 1.7.1 Market Drivers
    • 1.7.1.1 Increasing Adoption of Personalized Medicine for Screening and Diagnostics of Genetic Disorders such as Rare Diseases and Cancer
    • 1.7.1.2 Increasing Incidence of Infectious Diseases
    • 1.7.1.3 Technological Advancement in dPCR to Enhance Market Growth
  • 1.7.2 Market Restraints
    • 1.7.2.1 High Cost of Platforms Associated with Digital-PCR
    • 1.7.2.2 Shortage of Skilled Professionals and Trained Laboratory Technicians
  • 1.7.3 Market Opportunities
    • 1.7.3.1 Increased Use of Digital-PCR-Based Solutions for the Development of Therapeutics Drugs and Comprehensive Treatment Plan
    • 1.7.3.2 Growing Adoption of dPCR in Emerging Markets

2 Regions

• 2.1 Regional Summary
• 2.2 Drivers and Restraints
• 2.3 Asia-Pacific
  • 2.3.1 Regional Overview
  • 2.3.2 Driving Factors for Market Growth
  • 2.3.3 Factors Challenging the Market
  • 2.3.4 Application
  • 2.3.5 By End User
  • 2.3.6 China
  • 2.3.7 Australia
  • 2.3.8 South Korea
  • 2.3.9 Japan
  • 2.3.10 Rest-of-Asia-Pacific

3 Markets - Competitive Benchmarking & Company Profiles

• 3.1 Competitive Landscape
• 3.2 Market Share Analysis
• 3.3 Company Profile
  • 3.3.1 Genetron Holdings Limited
    • 3.3.1.1 Overview
    • 3.3.1.2 Top Products/Product Portfolio
    • 3.3.1.3 Top Competitors
    • 3.3.1.4 Target Customers
    • 3.3.1.5 Key Personnel
    • 3.3.1.6 Analyst View
  • 3.3.2 RevoSketch Inc.
    • 3.3.2.1 Overview
    • 3.3.2.2 Top Products/Product Portfolio
    • 3.3.2.3 Top Competitors
    • 3.3.2.4 Target Customers
    • 3.3.2.5 Key Personnel
    • 3.3.2.6 Analyst View
  • 3.3.3 JN Medsys
    • 3.3.3.1 Overview
    • 3.3.3.2 Top Products/Product Portfolio
    • 3.3.3.3 Top Competitors
    • 3.3.3.4 Target Customers
    • 3.3.3.5 Key Personnel
    • 3.3.3.6 Analyst View
  • 3.3.4 Sysmex Corporation.
    • 3.3.4.1 Overview
    • 3.3.4.2 Top Products/Product Portfolio
    • 3.3.4.3 Top Competitors
    • 3.3.4.4 Target Customers
    • 3.3.4.5 Key Personnel
    • 3.3.4.6 Analyst View

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation
• 4.2 Market Estimation and Forecast